Skip to main content

Downregulation of microRNA1835p inhibits the proliferation and invasion of colorectal cancer cells by inactivating the reticulocalbin2/Wnt/βcatenin signaling pathway

Buy Article:

$42.00 + tax (Refund Policy)

microRNAs (miRNAs) are frequently aberrantly expressed in colorectal cancer (CRC) and are considered to serve a critical role in the onset and development of CRC by binding to its target transcription factor. The aim of the present study was to examine the role of miRNA (miR)1835p in the proliferation, invasion and migration of CRC cells, in addition to its underlying mechanism. Reverse transcriptionquantitative polymerase chain reaction analysis was used to detect the expression level of miR1835p. MTT and Transwell assays were performed to examine proliferation and invasion in SW620 cells. Western blot analysis was performed to determine the protein expression of reticulocalbin2 (RCN2), matrix metalloproteinase2, βcatenin, cyclin D1 and cMyc. miR1835p expression was significantly upregulated in the CRC tissues compared with adjacent normal tissues. In addition, the inhibition of miR1835p suppressed proliferation, invasion and migration in SW620 cells. miR1835p downregulation or overexpression regulated the CRC cell cycle, invasion and migration by modulating RCN2 expression. Furthermore, the Wnt/βcatenin pathway was observed to be involved in the inhibitory effect of miR1835p downregulation in CRC cell proliferation, invasion and migration. These results provided evidence that the downregulation of miR1835p inhibits CRC proliferation and invasion by regulating the RCN2/Wnt/βcatenin pathway. miR1835p and RCN2 may serve an important role in the molecular etiology of CRC and have potential applications in CRC treatment.

Document Type: Research Article

Affiliations: Department of Gastrointestinal Surgery, The Second People's Hospital of Lianyungang, Haizhou, Jiangsu 310000, P.R. China

Publication date: 01 January 2019

More about this publication?
  • Molecular Medicine Reports is a monthly, peer-reviewed journal available in print and online, that includes studies devoted to molecular medicine, underscoring aspects including pharmacology, pathology, genetics, neurosciences, infectious diseases, molecular cardiology and molecular surgery. In vitro and in vivo studies of experimental model systems pertaining to the mechanisms of a variety of diseases offer researchers the necessary tools and knowledge with which to aid the diagnosis and treatment of human diseases.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content